| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Mar 04, 2016 | Mar 04, 2016 | Plunkett Matthew EVP Chief Business Officer | Sell | Cti Biopharma Corp | CTIC | $0.59 | $5,904 | -1.67% |
| Feb 04, 2016 | Feb 05, 2016 | Plunkett Matthew EVP Chief Business Officer | Sell | Cti Biopharma Corp | CTIC | $1.15 | $11,539 | -1.64% |
| Jan 04, 2016 | Jan 06, 2016 | Plunkett Matthew EVP Chief Business Officer | Sell | Cti Biopharma Corp | CTIC | $1.21 | $12,134 | -1.61% |
| Dec 04, 2015 | Dec 04, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1 | $9,969 | -1.59% |
| Nov 04, 2015 | Nov 06, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.38 | $13,814 | -1.56% |
| Oct 05, 2015 | Oct 07, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.52 | $15,204 | -1.54% |
| Sep 29, 2015 | Oct 01, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.41 | $106,052 | -10.34% |
| Sep 24, 2015 | Sep 25, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.57 | $119,041 | -9.47% |
| Sep 04, 2015 | Sep 04, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.54 | $15,355 | -1.52% |
| Aug 04, 2015 | Aug 06, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.84 | $18,426 | -1.47% |
| Jul 06, 2015 | Jul 08, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.95 | $19,493 | -1.45% |
| Jun 04, 2015 | Jun 05, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.06 | $20,613 | -1.43% |
| May 04, 2015 | May 04, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.86 | $18,553 | -1.41% |
| Apr 06, 2015 | Apr 08, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.88 | $31,182 | -2.27% |
| Mar 23, 2015 | Mar 24, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $1.96 | $116,029 | -7.51% |
| Mar 04, 2015 | Mar 06, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.41 | $28,939 | -1.40% |
| Feb 04, 2015 | Feb 06, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.22 | $26,651 | -1.38% |
| Jan 05, 2015 | Jan 08, 2015 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.36 | $28,365 | -2.96% |
| Dec 04, 2014 | Dec 05, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.23 | $26,808 | -2.87% |
| Nov 04, 2014 | Nov 07, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.39 | $28,665 | -2.79% |
| Oct 06, 2014 | Oct 08, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.39 | $28,733 | -2.72% |
| Sep 22, 2014 | Sep 24, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.56 | $264,918 | -18.99% |
| Sep 04, 2014 | Sep 05, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.48 | $67,617 | -4.77% |
| Aug 04, 2014 | Aug 06, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.48 | $29,722 | -2.05% |
| Jul 07, 2014 | Jul 09, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $2.89 | $34,699 | -2.01% |
| Jun 04, 2014 | Jun 06, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cti Biopharma Corp | CTIC | $3.02 | $36,256 | -1.97% |
| May 05, 2014 | May 07, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cell Therapeutics Inc | CTIC | $2.96 | $35,497 | -1.93% |
| Mar 21, 2014 | Mar 21, 2014 | Plunkett Matthew EVP Corporate Development | Sell | Cell Therapeutics Inc | CTIC | $3.73 | $633,384 | -21.49% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.